Citigroup’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Buy |
246,212
+155,701
| +172% | +$375K | ﹤0.01% | 2831 |
|
|
2025
Q1 | $200K | Sell |
90,511
-26,185
| -22% | -$57.9K | ﹤0.01% | 3437 |
|
|
2024
Q4 | $636K | Buy |
116,696
+6,086
| +6% | +$33.2K | ﹤0.01% | 2871 |
|
|
2024
Q3 | $919K | Buy |
110,610
+52,580
| +91% | +$437K | ﹤0.01% | 2619 |
|
|
2024
Q2 | $415K | Sell |
58,030
-142,788
| -71% | -$1.02M | ﹤0.01% | 2804 |
|
|
2024
Q1 | $1.74M | Buy |
200,818
+127,130
| +173% | +$1.1M | ﹤0.01% | 1934 |
|
|
2023
Q4 | $483K | Sell |
73,688
-107,878
| -59% | -$707K | ﹤0.01% | 2709 |
|
|
2023
Q3 | $1.82M | Sell |
181,566
-2,159,294
| -92% | -$21.6M | ﹤0.01% | 1533 |
|
|
2023
Q2 | $29.1M | Sell |
2,340,860
-84,158
| -3% | -$1.05M | 0.02% | 464 |
|
|
2023
Q1 | $34M | Buy |
2,425,018
+578,343
| +31% | +$8.1M | 0.02% | 406 |
|
|
2022
Q4 | $26.4M | Sell |
1,846,675
-190,079
| -9% | -$2.72M | 0.02% | 473 |
|
|
2022
Q3 | $52M | Buy |
2,036,754
+531,213
| +35% | +$13.6M | 0.04% | 256 |
|
|
2022
Q2 | $42.8M | Sell |
1,505,541
-19,681
| -1% | -$559K | 0.03% | 307 |
|
|
2022
Q1 | $53.8M | Buy |
1,525,222
+247,667
| +19% | +$8.74M | 0.03% | 324 |
|
|
2021
Q4 | $53.5M | Buy |
1,277,555
+393,133
| +44% | +$16.5M | 0.03% | 353 |
|
|
2021
Q3 | $43.4M | Buy |
884,422
+831,237
| +1,563% | +$40.8M | 0.03% | 410 |
|
|
2021
Q2 | $2.22M | Buy |
53,185
+45,093
| +557% | +$1.88M | ﹤0.01% | 2029 |
|
|
2021
Q1 | $288K | Buy |
8,092
+7,425
| +1,113% | +$264K | ﹤0.01% | 3165 |
|
|
2020
Q4 | $19K | Buy |
+667
| New | +$19K | ﹤0.01% | 4652 |
|